|
|||||
|
|
Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript |
|
| Authors: | Claire M. Lucas Robert J. Harris Athina Giannoudis Andrea Davies Katy Knight Sarah J. Watmough Lihui Wang Richard E. Clark |
| Affiliation: | Department of Haematology, Royal Liverpool University Hospital, Liverpool, UK |
| Abstract: | |
| Keywords: | |